Development and validation of an LC-MS/MS assay for the quantification of the trans-methylation pathway intermediates S-adenosylmethionine and S-adenosylhomocysteine in human plasma

Clinica Chimica Acta

Volumn 421, Issue , 2013, Pages 91-97

  Klepacki, Jacek ^a   Brunner, Nina ^b   Schmitz, Volker ^b   Klawitter, Jelena ^a   Christians, Uwe ^a   Klawitter, Jost ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute rejection; HPLC MS MS; Nephrotoxicity; S adenosylhomocysteine; S adenosylmethionine

Indexed keywords

MOLECULAR MARKER; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ACCURACY; ACUTE GRAFT REJECTION; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; KIDNEY TRANSPLANTATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; METHYLATION; NEPHROTOXICITY; PILOT STUDY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ADULT; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE;

EID: 84875642754     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.03.003     Document Type: Article

References (25)

1. Christians U., Klawitter J., Brunner N., Schmitz V. Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions. Expert Opin Drug Metab Toxicol 2011, 7:175-200.
2. Merville P. Combating chronic renal allograft dysfunction: optimal immunosuppressive regimens. Drugs 2005, 65:615-631.
3. Chapman J.R. Clinical renal transplantation: where are we now, what are our key challenges?. Transplant Proc 2010, 42:S3-S6.
4. Nankivell B.J., Alexander S.I. Rejection of the kidney allograft. N Engl J Med 2010, 363:1451-1462.
5. Alachkar N, Rabb H, Jaar BG. Urinary biomarkers in acute kidney transplant dysfunction. Nephron Clin Pract; 118:c173-c181.
6. Korbely R., Wilflingseder J., Perco P., et al. Molecular biomarker candidates of acute kidney injury in zero-hour renal transplant needle biopsies. Transpl Int 2011, 24:143-149.
7. Andrade F., Rodriguez-Soriano J., Prieto J.A., et al. Methylation cycle, arginine-creatine pathway and asymmetric dimethylarginine in paediatric renal transplant. Nephrol Dial Transplant 2011, 26:328-336.
8. Wagner C., Koury M.J. S-adenosylhomocysteine: a better indicator of vascular disease than homocysteine?. Am J Clin Nutr 2007, 86:1581-1585.
9. Kerins D.M., Koury M.J., Capdevila A., Rana S., Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 2001, 74:723-729.
10. Jabs K., Koury M.J., Dupont W.D., Wagner C. Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children. Metabolism 2006, 55:252-257.
11. Valli A., Carrero J.J., Qureshi A.R., et al. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clin Chim Acta 2008, 395:106-110.
12. Brosnan J.T., Brosnan M.E. The sulfur-containing amino acids: an overview. J Nutr 2006, 136:1636S-1640S.
13. Chiang P.K., Gordon R.K., Tal J., et al. S-adenosylmethionine and methylation. FASEB J 1996, 10:471-480.
14. Jiang Z., Liang Q., Luo G., Hu P., Li P., Wang Y. HPLC-electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols: application to studies of diabetic nephropathy. Talanta 2009, 77:1279-1284.
15. Kirsch S.H., Knapp J.P., Geisel J., Herrmann W., Obeid R. Simultaneous quantification of S-adenosyl methionine and S-adenosyl homocysteine in human plasma by stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:3865-3870.
16. Struys E.A., Jansen E.E., de Meer K., Jakobs C. Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin Chem 2000, 46:1650-1656.
17. Melnyk S., Pogribna M., Pogribny I.P., Yi P., James S.J. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations. Clin Chem 2000, 46:265-272.
18. Stabler S.P., Allen R.H. Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrometry. Clin Chem 2004, 50:365-372.
19. CDER U.S. Department of Health and Human Services, Food and Drug Administration, (CVM) CfDEaRaCfVM. Guidance for the industry. Bioanalytical method validation 2001, [2001:].
20. Tholen D. CLSI evaluation protocols. MLO Med Lab Obs 2006, 38(38):40-41.
21. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003, 75:3019-3030.
22. Armbruster D.A., Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008, 29(Suppl. 1):S49-S52.
23. Vogeser M., Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem 2010, 56:1234-1244.
24. Annesley T.M. Ion suppression in mass spectrometry. Clin Chem 2003, 49:1041-1044.
25. Nickel T., Schlichting C.L., Weis M. Drugs modulating endothelial function after transplantation. Transplantation 2006, 82:S41-S46.